MIR5100: A Drug Target / Disease Biomarker (G100847014)

Target Name: MIR5100

NCBI ID: G100847014

MIR5100

Other Name(s): hsa-miR-5100 | MicroRNA 5100 | hsa-mir-5100 | microRNA 5100

MIR5100: A Drug Target / Disease Biomarker

The MIR5100 protein is a protein that is expressed in various tissues of the body, including the brain, heart, lungs, and gastrointestinal tract. It is a member of the MIR gene family, which encodes for a variety of proteins that are involved in cell signaling pathways. One of the known functions of MIR5100 is that it is a drug target, which means that it can be targeted by small molecules in order to interfere with its function and potentially lead to therapeutic benefits.

MIR5100 is a 21-kDa protein that is expressed in the brain, heart, lungs, and gastrointestinal tract. It is characterized by a calculated molecular weight of 63.9 kDa and a calculated pI of 1.5. MIR5100 is a member of the MIR gene family, which encodes for a variety of proteins that are involved in cell signaling pathways. The MIR gene family has been implicated in the development and progression of a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the known functions of MIR5100 is that it is a drug target. This means that MIR5100 can be targeted by small molecules in order to interfere with its function and potentially lead to therapeutic benefits. The MIR5100 protein is thought to be involved in a number of different signaling pathways, including the TGF-β pathway, the Wnt pathway, and theNotch pathway. These pathways are involved in a variety of cellular processes, including cell growth, differentiation, and survival.

In addition to its potential role as a drug target, MIR5100 is also of interest as a biomarker. This is because it can be used as a protein biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The MIR5100 protein is thought to be involved in the development and progression of these diseases, which means that it may be a useful indicator of the severity and stage of these conditions.

One of the potential advantages of MIR5100 as a drug target is that it is located in a region of the body that is relatively accessible and can be targeted by small molecules. This is important because many drugs that are currently used to treat these types of diseases are systemic, meaning that they are taken throughout the body, and can have potential side effects. By targeting MIR5100 directly in certain tissues, researchers may be able to minimize the impact of these drugs on other parts of the body.

Another potential advantage of MIR5100 as a drug target is that it is involved in a number of different signaling pathways, which means that it may be a useful target for drugs that target multiple signaling pathways. This is important because many diseases are caused by the interruption of normal signaling pathways, and MIR5100 may be a useful target for drugs that can help restore these pathways.

MIR5100 is also of interest as a biomarker because it is expressed in a variety of tissues and cells of the body. This means that it may be a useful indicator of the presence and severity of many different types of diseases. For example, MIR5100 may be expressed in the brains of people with Alzheimer's disease, which is a neurodegenerative disorder that is characterized by the progressive loss of brain cells. It may also be expressed in the hearts of people with heart failure, which is a condition that is characterized by the progressive loss of muscle mass and the inability to pump blood efficiently.

In conclusion, MIR5100 is a protein that is expressed in various tissues of the body and is known to be involved in the TGF-β, Wnt, and Notch pathways. It is also a potential drug target and biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The MIR5100 protein is located in a region of the body that is relatively accessible and may be a useful target for small molecules used to treat these

Protein Name: MicroRNA 5100

The "MIR5100 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR5100 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets